Lysosomal Therapeutics, Inc. is developing novel therapies for severe neurodegenerative diseases including Gaucher’s and Parkinson’s.
| Headquarters | Cambridge, MA |
| Website | www.lysosomaltx.com |
| Pipeline | Phase 1b |
| Partnerships | Allergan |
Lysosomal Therapeutics, Inc.
